PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free technology, today announced their upcoming poster presentation on November 13, ...
The postulated mechanisms of injury include direct needle trauma, secondary constriction ... Follow-up of 151 patients for an average 8.5 years revealed excellent to good nerve recovery (i.e ...
Skip More from 5 Live... The 5 Live at 30 Yearbook How 5 Live reported on some of the biggest news and sport stories of the past 30 years. Eleanor Oldroyd: 30 years of "my radio family" Eleanor ...
Mean (% coefficient of variation) bioavailability of intranasal hydromorphone was 54.4% (34.8) and 59. ... the avoidance of needles associated with intravenous (IV) or intramuscular (IM ...
The Body Composition Monitor and Scale Market, valued at USD 644.7 Million in 2024, Is Set for Substantial Growth, projected to Reach USD 1.31 Billio ...
The Nasal Drug Delivery Technology Market is driven by the rising demand for non-invasive administration methods that enhance patient compliance and bioavailability. Innovations such as advanced ...
Reported positive YTD 2024 Adjusted EBITDA of $1.4 million Company expects Q4 2024 Net Revenue in the range of $37 million - $43 million ZYNRELEF® (bupivacaine ...